Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion description "[ChoK? specific inhibitors, MN58b and TCD-717, have demonstrated a potent antitumoral activity both in vitro and in vivo against several tumor-derived cell line xenografts including CRC-derived cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion evidence source_evidence_literature NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion SIO_000772 23762272 NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion wasDerivedFrom befree-20140225 NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_assertion wasGeneratedBy ECO_0000203 NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.
- befree-20140225 importedOn "2014-02-25" NP871417.RAXmMARtg_OWlQ5fbPk5XeaG8qOAbOQGgie8rOmDwmQDc130_provenance.